Trezix Capsule
NDC Package 63187-705-72

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Trezix (acetaminophen, caffeine, dihydrocodeine bitartrate) capsules is see also Warning section. This formulation utilizes a capsule delivery system. Marketed by Proficient Rx Lp, this product is identified by NDC 63187-705 and is authorized under FDA application ANDA204785.

Identification & Billing

NDC Package Code
63187-705-72
Package Description
120 CAPSULE in 1 BOTTLE
Product Code
63187-705
11-Digit Billing Format
63187070572
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
120 EA
RxNorm Crosswalk
  • RxCUI: 1190201 - TREZIX 16 MG / 320.5 MG / 30 MG Oral Capsule
  • RxCUI: 1190201 - acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]
  • RxCUI: 1190201 - APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]
  • RxCUI: 1190201 - Trezix (acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG) Oral Capsule
  • RxCUI: 1596108 - acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule

Clinical Specifications

Proprietary Name
Trezix
Non-Proprietary Name
Acetaminophen, Caffeine, Dihydrocodeine Bitartrate
Substance Name
Acetaminophen; Caffeine; Dihydrocodeine Bitartrate
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
See also Warning section. This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (dihydrocodeine), a non-opioid pain reliever (acetaminophen), and caffeine. Dihydrocodeine works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. Caffeine increases pain relief, especially for certain types of headaches.
DEA Schedule
Schedule III (CIII) Substances

Regulatory & Marketing

Labeler Name
Proficient Rx Lp
Product Type
Human Prescription Drug
FDA Application #
ANDA204785
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-01-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (63187-705). Click a package code to view its specific billing and regulatory data.

63187-705-00
100 CAPSULE in 1 BOTTLE
63187-705-30
30 CAPSULE in 1 BOTTLE
63187-705-60
60 CAPSULE in 1 BOTTLE
63187-705-90
90 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63187-705-72 identifies a specific commercial package of 120 capsule in 1 bottle of Trezix, a human prescription drug labeled by Proficient Rx Lp. This product is billed for "EA" each discreet unit and contains an estimated amount of 120 billable units per package. This capsule is formulated for oral use and contains acetaminophen; caffeine; dihydrocodeine bitartrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Proficient Rx Lp on December 01, 2014. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

See also Warning section. This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (dihydrocodeine), a non-opioid pain reliever (acetaminophen), and caffeine. Dihydrocodeine works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. Caffeine increases pain relief, especially for certain types of headaches.

How is this Proficient Rx Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63187070572. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 120 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63187-705-72
11-Digit CMS (5-4-2)
63187-0705-72

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.